摘要
目的探讨基质金属蛋白酶(MMP)-9调控CD73自视网膜色素上皮(RPE)细胞膜表面脱落的机制。方法以脂多糖及肿瘤坏死因子-α共同干预体外培养的人RPE细胞,诱导RPE细胞膜表面CD73脱落。同时给予磷脂酶C(PLC)抑制剂ET-18-OCH,30.0gmol/L或广谱MMP抑制剂ONO-48175.0gmol/L进行干预;流式细胞仪检测RPE细胞膜表面CD73含量变化。以选择性MMP.2、MMP-9抑制剂或相应siRNA进行干预;利用基因定点突变技术改造CD73中潜在的MMP.9识别位点,在CD73^-/-。RPE细胞中过表达野生型(Wt)及突变型(Mut)CD73,检Nwt、Mut.CD73脱落情况。结果广谱MMP抑制剂可有效抑制CD73自RPE细胞膜表面脱落;PLC抑制剂不能抑制CD73自RPE细胞膜表面脱落。选择性抑制MMP-9活性或以siRNAT调MMP-9的表达也均可抑制CD73自RPE细胞膜表面脱落。表达于CD73。RPE细胞膜表面的Wt.CD73可发生脱落,而Lys^547Phe^548编码位点突变的CD73未见脱落。结论MMP.9通过水解Lys^547Phe^548位点而参与炎症状态下CD73自RPE细胞膜表面的脱落。
Objective To study how CD73 is shed from the retinal pigment epithelium (RPE) surface. Methods CD73 shedding was induced by treating RPE with lipopolysaccharides (LPS) and TNF-α. After Phospholipase C (PLC) or pan matrix metalloproteinase (MMP) inhibitors were added, surface amount of CD73 was evaluated by flow cytometry (FACS). Then selective inhibitors or their corresponding siRNAs of MMP-2 and MMP-9 were applied to the treatments of RPE; and their effects on induced CD73 shedding were evaluated by FACS. By site directed mutagenesis, mutations were introduced to Lys547-Phe548 coding sites of CD73 cDNA, which was cloned in a pcDNA mammalian expression vector. Both wt-CD73 and mutated-CD73 were over expressed in CD73/ RPE and their induced shedding was compared. Results LPS and TNF-α induced CD73 shedding from RPE was completely blocked by the addition of pan MMP inhibitor but not PLC inhibitor. Selective MPP-9, but not MMP-2, inhibitor or its siRNA blocked CD73 shedding. In CD73/ RPE induced CD73 shedding was happened to overexpressed wt-CD73 but not Lyss47- Phe548 sites mutant CD73. Conclusion MMP-9 is responsible for shedding CD73 from RPE through hydrolyzing its Lys547 -Phe548 sites.
出处
《中华眼底病杂志》
CSCD
北大核心
2017年第5期518-522,共5页
Chinese Journal of Ocular Fundus Diseases
基金
国家自然科学基金(81570833)